JLR junior associate editors organize virtual issues
The junior associate editors of the Journal of Lipid Research have organized four virtual issues highlighting cutting-edge research published by the journal.
Lipoprotein (a): Many strides made, yet there is a long road ahead
In this virtual issue, the JLR highlights early-career researchers pushing our understanding of lipoprotein (a) pathophysiology forward. According to Gissette Reyes-Soffer of the Columbia University Irving Medical Center, a better grasp of lipoprotein (a) is necessary to improve risk evaluations and targeted therapies for cardiovascular disease and diabetes.
The cover art depicts the Lp(a) particle following the steps of a walking path, increasing in size as the road goes into infinity. Read the collection.
Solving the enigma of the sphinx, one sphingolipid at a time
Recent studies have advanced our understanding of sphingolipids and their biologic roles in health and disease. This virtual issue, organized by Rotonya Carr of the University of Pennsylvania Perelman School of Medicine, also highlights both established and new investigators in the field who undoubtedly are the future of sphingolipid research.
The cover art features the structures of several sphingolipids being freed as the Sphinx unravels. Read the collection.
Exploring the nuances and complexity of lipoprotein clearance
This virtual issue, assembled by Brandon Davies of the University of Iowa Carver College of Medicine, highlights studies that advance our understanding of lipoprotein clearance and illustrate the breadth and diversity of lipoprotein-clearance research.
The cover art depicts different mechanisms acting to clear and modify lipoproteins on an assembly line representing the circulation. Read the collection.
Lipids in transcription and chromatin biology
Ray Blind of the Vanderbilt University School of Medicine put together a virtual issue showcasing recent papers showing that lipids actively participate in epigenetic reprogramming, chromatin modifications and nucleosome structure, along with their more well-established roles in splicing, RNA export and transcriptional regulation.
The cover art is an abstract representation of nuclear lipids participating in the regulation of transcription and chromatin biology. Read the collection.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Spider-like proteins spin defenses to control immunity
Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.
A biological camera: How AI is transforming retinal imaging
AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.
AI in the lab: The power of smarter questions
An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.
Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.
AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.
Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.